Bespak is increasing pressurized metered dose inhaler manufacturing capacity to support Chiesi Group’s Carbon Minimal Inhaler (CMI) program.

Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the ...

Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...

A new U.S. study found Anoro Elipta to be better than Bevespi Aerosphere or Stiolto Respimat at lowering the risk of disease flares in COPD.

"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...

Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...

This week investors have been bombarded with dire reports of a new oil price shock, rampant inflation and serious trade and ...

Although plastic particles in the air are increasingly coming into focus, knowledge about their distribution and effects is still limited. Chemical analyses from Leipzig now provide details from ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

INHALERS prescribed for asthma and COPD generated nearly 25 million metric tons of greenhouse gas emissions in the United States over the past decade, according to a new serial cross-sectional ...